Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,030 public trials 1,171 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden

NCT00960557

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • OXiGENE Investigational Site Westmead, New South Wales, Australia
  • OXiGENE Investigational Site South Brisbane, Queensland, Australia
  • OXiGENE Investigational Site Adelaide, South Australia, Australia
  • OXiGENE Investigational Site Bentleigh, Victoria, Australia
View Trial Details
Completed

Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma

NCT00073736

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University of California at Irvine Orange, California, United States
  • Prince of Wales Hospital - Comprehensive Cancer Trial Unit Shatin, New Territories, Hong Kong
  • Tri-Services General Hospital Taipei, Nei Hu District, Taiwan
  • Chang-Gung Memorial Hospital Taipei, Taoyuan County, Taiwan
View Trial Details
Completed

Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma

NCT00444314

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States
View Trial Details

Related conditions